Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-23-087548
Filing Date
2023-08-04
Accepted
2023-08-04 07:25:24
Documents
12
Period of Report
2023-05-03
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2322811d1_8ka.htm   iXBRL 8-K/A 29176
  Complete submission text file 0001104659-23-087548.txt   202128

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA twst-20230503.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE twst-20230503_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE twst-20230503_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2322811d1_8ka_htm.xml XML 3203
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K/A | Act: 34 | File No.: 001-38720 | Film No.: 231142156
SIC: 2836 Biological Products, (No Diagnostic Substances)